Abstract
Instructions and Submission
AMERICAN
OTOLOGICAL SOCIETY, INC.
The One Hundred Forty-Third Annual Meeting
Bally’s/Paris Las Vegas
Las Vegas, NV
May 1-2, 2010
Deadline for abstract submission: October 15, 2009
The
abstract submission form is now closed, thank you for your abstracts
Abstract Submission Instructions: Please read all instructions
carefully. Failure to comply with the instructions could delay
the review of or disqualify your
abstract submission.
Please contact the AOS Administrative Office if you have
any questions prior to submitting your abstract.
Email - segossard@aol.com
Ph: 352-751-0932
Cell: 217-414-4868
The American Otological Society accepts on-line submission of abstracts to
www.americanotologicalsociety.org. The electronic version is not to contain any
extraneous formatting instructions.
Acknowledgment of receipt of an electronic submission will be sent electronically
during the submission process to the primary author.
The AOS Program Advisory Committee will not consider abstracts that do not contain
the required elements.
Abstracts must be structured according to Otology & Neurotology Guidelines
for Authors
General Format:
A concise abstract of not more than 250 words or less is required for all original
clinical and basic science contributions, including review articles. The AOS
Program Advisory Committee for selection reviews all abstracts anonymously; please
do not place any identifying information in the body of the abstract, such as
referral to authorship or institution. Also, if the research in your paper is
supported by a grant, or special financial arrangement, this must be identified.
These should be organized according to the headings outlined below. The author(s)
must accept sole responsibility for statements in their submitted abstract.
Choose an appropriate title reflecting the content of the abstract body.
The title will appear in all publications if chosen for presentation. Do
not capitalize
prepositions, a, an, the, etc. No changes to abstract will be accepted
after October 15. Do not include the author’s name(s) in the abstract
title or body of the abstract.
List all authors in proper sequence (numbering 1, 2, 3, etc., if applicable)
using first names, middle initials, and last names and exact degrees. Specify
the primary author and the presenter of the abstract. Please specify a corresponding
author to whom all correspondence about the abstract will be directed.
The AOS Program Advisory Committee will require a completed manuscript
to the Otology & Neurotology Journal three weeks before the scientific
meeting so the Program Advisory Committee has an opportunity to review
the manuscript
for
any commercial bias, conflict of interest, use of commercial names and
any other identifying information that may conflict with the ACCME requirements.
The program
committee may ask you to revise submitted abstract to enforce compliance
with the ACCME requirements.
For clinical studies:
Objective: Brief, clear statement of the main goals of the investigation.
Study design: Specify the type of study-randomized, prospective double blind;
retrospective case review; etc.
Setting: Primary care vs. Tertiary referral center; ambulatory vs. hospital;
etc.
Patients: Primary eligibility criteria and key demographic features.
Intervention(s): Diagnostic, therapeutic, and/or rehabilitative.
Main outcome measure(s): The most essential criterion that addresses the
study’s
central hypothesis.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this
study.
For basic science reports:
Hypothesis: Brief, clear statement of the main goals of the investigation.
Background: Concise orientation for the reader unfamiliar with this line of investigation.
Methods: Succinct summary of techniques and materials employed.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this
study. Emphasize clinical relevance wherever possible.
For reviews and meta-analysis:
Objective: Brief, clear statement of the goals of the review.
Data sources: Specify database, search methodology, languages covered, and time
frame.
Study selection: Criteria used to select articles for detailed review.
Data extraction: Means of assessing quality, validity, and comparability of extracted
data.
Data synthesis: Specify statistical techniques used for data analysis.
Conclusions: Concise statement of primary inferences with any recommendations.
For All Human Studies: Indicate IRB Approval Number
Support/Acknowledgment:
Author Responsibility/Financial Disclosure/Conflict of Interest & Attestation
Form:
All authors (primary and contributing) are responsible for disclosing any potential
conflict of interest. Conflict of interest of an individual has two components:
1) a financial relationship with a commercial interest (e.g., pharmaceutical
company or medical device manufacturer) and, 2) the opportunity to influence
content of a CME activity relevant to products and services of that commercial
interest. In addition, all authors must agree to disclose all non-FDA approved
use of FDA approved drugs at the time of abstract submission and prior to the
actual oral presentation should your abstract be selected for presentation.
In order to comply with the ACCME requirements, all primary and contributing
authors are required to complete a financial Disclosure/Conflict of Interest & Attestation
form at the time of abstract submission. This form is for the annual spring
meeting.
Click here to fill out the Conflict
of Interest/Disclosure & Attestation
form and submit electronically. The primary author accepts responsibility to
secure conflict of interest/disclosure statements from all co-authors. If you
do not have an electronic signature, please fax your completed form with full
name, designation and signature to the AOS Administrative office at 352-751-0696.
IDENTIFICATION OF PROFESSIONAL PRACTICE GAPS
Professional practice gaps are the variations or differences in the practice
patterns when compared to current evidence, standards of care or clinical guidelines
that are designed to provide quality of care to patients. Describe how you translate
identified professional practice gaps into educational needs; how the need is
expressed in terms of knowledge, competence, performance and patient outcome;
what should the learners be able to apply to their profession after they participate
in the educational activity; list the desire results in terms of changes in physician
knowledge, competence, performance and/or patient outcome.
Please identify the professional practice gaps, educational needs, learning objectives,
and desired results
Define Professional Practice Gap:
Educational Need:
Check all that apply: •Knowledge •Competence •Performance •Patient Outcomes
Learning Objective:
Desired Result:
The following competency areas will be addressed - Please place a check in the
(any/all) competency areas your presentation will address
• Patient Care that is compassionate, appropriate, and effective for the
treatment of health problems and the promotion of health
• Medical Knowledge about established and evolving biomedical, clinical,
and cognate (e.g. epidemiological and social-behavioral) sciences and the application
of this knowledge to patient care
• Practice-Based Learning and Improvement that involves investigation and
evaluation of their own patient care, appraisal and assimilation of scientific
evidence,
and improvements in patient care
• Interpersonal and Communication Skills that result in effective information
exchange and teaming with patients, their families, and other health professionals
• Professionalism as manifested through a commitment to carrying out professional
responsibilities, adherence to ethical principles, and sensitivity to a diverse
patient population
• Systems-Based Practice as manifested by actions that demonstrate an awareness
of and responsiveness to the larger context and system of health care and the
ability to effectively call on system resources to provide care that is of
optimal value.
TITLE OF ABSTRACT: Capitalize each word in the title, use same format for the
body of the abstract. Do not include the author’s name(s). (No changes
accepted after 10/15/09)
AUTHORS: List all authors in proper sequence (numbering 1, 2, 3, etc., if applicable)
using FIRST NAMES, MIDDLE INITIALS, AND LAST NAMES AND EXACT DEGREES. (No changes
accepted after 10/15/09)
NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRIMARY AUTHOR:
NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRESENTER AT COSM IF OTHER
THAN THE PRIMARY AUTHOR:
Abstract (250 words or less)
Copyright Transmittal: Abstracts are received with the understanding that they
are not under simultaneous consideration by another publication and that they
are original contributions that have not been previously published. Accepted
abstracts become the permanent property of Otology & Neurotology and may
not be published elsewhere without permission from Otology & Neurotology.
Publication Statement: The material in this abstract, ( ) has not been submitted
for publication, published, or presented previously at another national or
international meeting and is not under consideration for presentation at another
national or international meeting including another COSM society. The penalty
for duplicate presentation/publication is prohibition of the author from presenting
at a COSM society meeting for a period of three years. Submitting author’s
signature required Will accept via e-mail printed name as your signature.
To
download an example of the 2010 Abstract Form, click
here
|
